| MeSH term | MeSH ID | Detail |
|---|---|---|
| Anemia, Iron-Deficiency | D018798 | 6 associated lipids |
| Thrombophlebitis | D013924 | 6 associated lipids |
| Blood Loss, Surgical | D016063 | 6 associated lipids |
| Jaundice, Neonatal | D007567 | 7 associated lipids |
| Mycobacterium Infections | D009164 | 7 associated lipids |
| Postoperative Hemorrhage | D019106 | 7 associated lipids |
| Leprosy | D007918 | 8 associated lipids |
| Renal Insufficiency, Chronic | D051436 | 9 associated lipids |
| Ascorbic Acid Deficiency | D001206 | 9 associated lipids |
| Hearing Disorders | D006311 | 10 associated lipids |
Glucaric acid
Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
Cross Reference
Introduction
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Glucaric acid?
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Glucaric acid
PubChem Associated disorders and diseases
What pathways are associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Glucaric acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Glucaric acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Glucaric acid?
There are no associated biomedical information in the current reference collection.
What genes are associated with Glucaric acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Glucaric acid?
Knock-out
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Glucaric acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Vindal V et al. | GntR family of regulators in Mycobacterium smegmatis: a sequence and structure based characterization. | 2007 | BMC Genomics | pmid:17714599 |
| Francis GS and Kanderian A | Anemia and heart failure a new pathway? | 2007 | J. Am. Coll. Cardiol. | pmid:17950148 |
| Beck-da-Silva L et al. | Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia. | 2007 | J. Card. Fail. | pmid:17338998 |
| Sane R et al. | Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate. | 2007 | Pharmacotherapy | pmid:17381390 |
| Breymann C et al. | Milk iron content in breast-feeding mothers after administration of intravenous iron sucrose complex. | 2007 | J Perinat Med | pmid:17302514 |
| Breborowicz A et al. | Peritoneal effects of intravenous iron sucrose administration in rats. | 2007 | Transl Res | pmid:17543848 |
| Sav T et al. | Is there a difference between the allergic potencies of the iron sucrose and low molecular weight iron dextran? | 2007 | Ren Fail | pmid:17497463 |
| Pai AB et al. | Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis. | 2007 | Pharmacotherapy | pmid:17316146 |
| Vikrant S | Optimum dosage regimen for iron sucrose. | 2007 | Kidney Int. | pmid:17625585 |
| Reed J et al. | The safety of intravenous iron sucrose use in the elderly patient. | 2007 | Consult Pharm | pmid:17658969 |
| Auerbach M and Rodgers GM | Intravenous iron. | 2007 | N. Engl. J. Med. | pmid:17611217 |
| Agarwal R et al. | Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. | 2007 | Kidney Int. | pmid:17622274 |
| Marsillach J et al. | Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia. | 2007 | Clin. Exp. Pharmacol. Physiol. | pmid:17324148 |
| Thomas J and Martinez A | Blood conservation in the critically ill. | 2007 | Am J Health Syst Pharm | pmid:17687066 |
| Malindretos P et al. | Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran. | 2007 | Am. J. Nephrol. | pmid:17804904 |
| Davey CL et al. | Esterification of select polyols with D-glucaric acid as model reactions for esterification of starch. | 2006 | Carbohydr. Res. | pmid:16973136 |
| Bolger AP et al. | Intravenous iron alone for the treatment of anemia in patients with chronic heart failure. | 2006 | J. Am. Coll. Cardiol. | pmid:16979010 |
| Kato M et al. | Tetranuclear copper(II) complexes bridged by alpha-D-glucose-1-phosphate and incorporation of sugar acids through the Cu4 core structural changes. | 2006 | Inorg Chem | pmid:16903719 |
| GarcÃa-Erce JA et al. | Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. | 2006 | Transfus Med | pmid:16999756 |
| Carlini RG et al. | Apoptotic stress pathway activation mediated by iron on endothelial cells in vitro. | 2006 | Nephrol. Dial. Transplant. | pmid:16957011 |
| Agarwal R | Is i.v. iron really superior in CKD patients not on dialysis? | 2006 | Kidney Int. | pmid:16957750 |
| Coletta AP et al. | Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902. | 2006 | Eur. J. Heart Fail. | pmid:16887387 |
| Eiselt J et al. | The effect of intravenous iron on oxidative stress in hemodialysis patients at various levels of vitamin C. | 2006 | Blood Purif. | pmid:17077626 |
| Sirken G et al. | Association of different intravenous iron preparations with risk of bacteremia in maintenance hemodialysis patients. | 2006 | Clin. Nephrol. | pmid:17140164 |
| Breborowicz A et al. | Iron sucrose induced morphological and functional changes in the rat kidney. | 2006 | Transl Res | pmid:17145571 |
| Schiesser D et al. | Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients. | 2006 | Nephrol. Dial. Transplant. | pmid:16891647 |
| Sudan C et al. | Ubiquitous presence of beta-glucuronidase (GUS) in plants and its regulation in some model plants. | 2006 | Planta | pmid:16652220 |
| Koutroubakis IE et al. | Effectiveness of darbepoetin-alfa in combination with intravenous iron sucrose in patients with inflammatory bowel disease and refractory anaemia: a pilot study. | 2006 | Eur J Gastroenterol Hepatol | pmid:16538115 |
| Guz G et al. | Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients. | 2006 | Nephrol. Dial. Transplant. | pmid:16762960 |
| Barton Pai A et al. | Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucrose. | 2006 | Am. J. Nephrol. | pmid:16809897 |
| Muñoz M et al. | Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. | 2006 | Transfus Med | pmid:16623920 |
| Bhandal N and Russell R | Intravenous versus oral iron therapy for postpartum anaemia. | 2006 | BJOG | pmid:17004982 |
| Agarwal R | Proinflammatory effects of iron sucrose in chronic kidney disease. | 2006 | Kidney Int. | pmid:16609688 |
| Brown SD et al. | A gold standard set of mechanistically diverse enzyme superfamilies. | 2006 | Genome Biol. | pmid:16507141 |
| Ranfaing E | [Treatments of the martial deficiencies: preparations available in France]. | 2006 | Nephrol. Ther. | pmid:17373280 |
| Singh H et al. | Effect of intravenous iron sucrose in peritoneal dialysis patients who receive erythropoiesis-stimulating agents for anemia: a randomized, controlled trial. | 2006 | Clin J Am Soc Nephrol | pmid:17699248 |
| Bishu K and Agarwal R | Acute injury with intravenous iron and concerns regarding long-term safety. | 2006 | Clin J Am Soc Nephrol | pmid:17699372 |
| Zager RA | Parenteral iron compounds: potent oxidants but mainstays of anemia management in chronic renal disease. | 2006 | Clin J Am Soc Nephrol | pmid:17699373 |
| Karkouti K et al. | Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia. | 2006 | Can J Anaesth | pmid:16371604 |
| Zheng H et al. | Iron sucrose augments homocysteine-induced endothelial dysfunction in normal subjects. | 2006 | Kidney Int. | pmid:16395269 |
| Johnson G et al. | (99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium. | 2006 | Eur. J. Nucl. Med. Mol. Imaging | pmid:16237571 |
| Cançado RD et al. | [Evaluation of the efficacy of intravenous iron III-hydroxide saccharate for treating adult patients with iron deficiency anemia]. | 2005 Nov-Dec | Rev Assoc Med Bras (1992) | pmid:16444338 |
| Pecharki GD et al. | Effect of sucrose containing iron (II) on dental biofilm and enamel demineralization in situ. | 2005 Mar-Apr | Caries Res. | pmid:15741724 |
| Al-Mueilo SH | Beneficial effects of maintenance intravenous iron saccharate in hemodialysis patients. | 2005 Apr-Jun | Saudi J Kidney Dis Transpl | pmid:18202490 |
| Agarwal R | Ironing out the mystery of nephrotoxicity of parenteral iron. | 2005 | J. Lab. Clin. Med. | pmid:16025083 |
| Sanai T et al. | Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats. | 2005 | J. Lab. Clin. Med. | pmid:16025088 |
| Macdougall IC and Roche A | Administration of intravenous iron sucrose as a 2-minute push to CKD patients: a prospective evaluation of 2,297 injections. | 2005 | Am. J. Kidney Dis. | pmid:16112047 |
| Perek N et al. | MRP-1 protein expression and glutathione content of in vitro tumor cell lines derived from human glioma carcinoma U-87-MG do not interact with 99mTc-glucarate uptake. | 2005 | Cancer Biother. Radiopharm. | pmid:16114987 |
| Bontchev RP and Moore RC | Crystal structure and aqueous solubility of ammonium D-glucarate. | 2005 | Carbohydr. Res. | pmid:16043161 |
| Wood DM et al. | Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child. | 2005 | Ther Drug Monit | pmid:16044093 |
| Sheashaa H et al. | Parenteral iron therapy in treatment of anemia in end-stage renal disease patients: a comparative study between iron saccharate and gluconate. | 2005 | Nephron Clin Pract | pmid:15692217 |
| Keven K et al. | Combination of intravenous iron sucrose and ascorbic acid in hemodialysis patients. | 2005 | Kidney Int. | pmid:15954940 |
| Anbu AT et al. | Low incidence of adverse events following 90-minute and 3-minute infusions of intravenous iron sucrose in children on erythropoietin. | 2005 | Acta Paediatr. | pmid:16431410 |
| Zager RA | Parenteral iron treatment induces MCP-1 accumulation in plasma, normal kidneys, and in experimental nephropathy. | 2005 | Kidney Int. | pmid:16164630 |
| Erichsen K et al. | Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease. | 2005 | Scand. J. Gastroenterol. | pmid:16165718 |
| St Peter WL et al. | Trends in intravenous iron use among dialysis patients in the United States (1994-2002). | 2005 | Am. J. Kidney Dis. | pmid:16183420 |
| Ayotte P et al. | Biomarker measurements in a coastal fish-eating population environmentally exposed to organochlorines. | 2005 | Environ. Health Perspect. | pmid:16203240 |
| Liu Y and Reineke TM | Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery. | 2005 | J. Am. Chem. Soc. | pmid:15740138 |
| Georgopoulos D et al. | Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]. | 2005 | Crit Care | pmid:16277712 |
| Laman CA et al. | Parenteral iron therapy: a single institution's experience over a 5-year period. | 2005 | J Natl Compr Canc Netw | pmid:16316614 |
| Strolin Benedetti M et al. | Induction of endogenous pathways by antiepileptics and clinical implications. | 2005 | Fundam Clin Pharmacol | pmid:16176329 |
| Breymann C | Treatment of iron deficiency anaemia in pregnancy and postpartum with special focus on intravenous iron sucrose complex. | 2005 | J Med Assoc Thai | pmid:17718296 |
| Cuenca J et al. | Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data. | 2005 | Arch Orthop Trauma Surg | pmid:15789233 |
| Tutor-Crespo MJ et al. | Effect of antiepileptic drugs on the urinary excretion of porphyrins in non-porphyric subjects. | 2005 | J. Pharmacol. Sci. | pmid:16314692 |
| Schaller G et al. | Intravenous iron increases labile serum iron but does not impair forearm blood flow reactivity in dialysis patients. | 2005 | Kidney Int. | pmid:16316358 |
| Van Wyck DB et al. | A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. | 2005 | Kidney Int. | pmid:16316362 |
| Anemia during pregnancy and in the postpartum: intravenous iron therapy revisited. | 2005 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:16360535 | |
| Govan AD and Scott JM | Intravenous iron in the treatment of anemia of pregnancy. 1949. | 2005 | Eur. J. Obstet. Gynecol. Reprod. Biol. | pmid:16360540 |
| Ozdemir A et al. | Relationship between iron replacement and hepatic functions in hepatitis C virus-positive chronic haemodialysis patients. | 2005 | Nephrology (Carlton) | pmid:16221090 |
| Spiegel K et al. | Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. | 2005 | J. Appl. Physiol. | pmid:16227462 |
| Aime S et al. | para-Hydrogenation of unsaturated moieties on poly(lysine) derived substrates for the development of novel hyperpolarized MRI contrast agents. | 2005 | Org. Biomol. Chem. | pmid:16240012 |
| Schröder O et al. | Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study. | 2005 | Am. J. Gastroenterol. | pmid:16279906 |
| Sengölge G et al. | Intravenous iron therapy: well-tolerated, yet not harmless. | 2005 | Eur. J. Clin. Invest. | pmid:16281958 |
| Agarwal R | On the nature of proteinuria with acute renal injury in patients with chronic kidney disease. | 2005 | Am. J. Physiol. Renal Physiol. | pmid:15467003 |
| Leijn E et al. | Intravenous iron supplementation in children on hemodialysis. | 2004 May-Jun | J. Nephrol. | pmid:15365964 |
| Verma P et al. | Decolorization of synthetic dyes using a copper complex with glucaric acid. | 2004 | Chemosphere | pmid:14575741 |
| Cuenca J et al. | Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. | 2004 | Transfusion | pmid:15383017 |
| Schwenk MH and Blaustein DA | Rapid, high-dose intravenous iron sucrose therapy in 2 Jehovah's Witness patients with severe anemia, iron deficiency and chronic kidney disease. | 2004 | Clin. Nephrol. | pmid:15356968 |
| Tiranathanagul K et al. | Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients. | 2004 | Nephrology (Carlton) | pmid:15363053 |
| McMahon LP et al. | Effects of different dialysis membranes on serum concentrations of epoetin alfa, darbepoetin alfa, enoxaparin, and iron sucrose during dialysis. | 2004 | Am. J. Kidney Dis. | pmid:15332224 |
| Schröder O et al. | A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding. | 2004 | Z Gastroenterol | pmid:15314711 |
| Tutor-Crespo MJ et al. | Possible induction of cholinesterase in epileptic patients treated with anticonvulsant drugs: relationship with lipoprotein levels. | 2004 | J Clin Pharmacol | pmid:15317825 |
| Agarwal R | Transferrin saturation with intravenous irons: an in vitro study. | 2004 | Kidney Int. | pmid:15327409 |
| Aronoff GR et al. | Iron sucrose in hemodialysis patients: safety of replacement and maintenance regimens. | 2004 | Kidney Int. | pmid:15327417 |
| Liu Z et al. | 99mTc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in SCID mice. | 2004 | Nucl Med Commun | pmid:15208499 |
| Liu Y et al. | New poly(d-glucaramidoamine)s induce DNA nanoparticle formation and efficient gene delivery into mammalian cells. | 2004 | J. Am. Chem. Soc. | pmid:15198572 |
| Zager RA et al. | Parenteral iron nephrotoxicity: potential mechanisms and consequences. | 2004 | Kidney Int. | pmid:15200421 |
| Dornyei A et al. | Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution. | 2004 | Dalton Trans | pmid:15381996 |
| Hanausek M et al. | Modulation of biomarkers during chemoprevention of mouse lung tumorigenesis by D-glucarate. | 2004 | Chest | pmid:15136473 |
| Silverstein SB and Rodgers GM | Parenteral iron therapy options. | 2004 | Am. J. Hematol. | pmid:15114602 |
| Okada DR et al. | Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate. | 2004 | J. Nucl. Med. | pmid:15073263 |
| Manley HJ and Grabe DW | Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study. | 2004 | BMC Nephrol | pmid:14718064 |
| Tutor-Crespo M et al. | Isoforms of serum gamma-glutamyltransferase in epileptic patients treated with enzyme-inducing anticonvulsant drugs. | 2004 | J Pharm Pharm Sci | pmid:15576017 |
| Silverberg D et al. | The use of androgens in anaemia resistant to erythropoietin and i.v. iron in patients with heart and renal failure. | 2004 | Nephrol. Dial. Transplant. | pmid:15031380 |
| Liu Z et al. | High-resolution imaging with (99m)Tc-glucarate for assessing myocardial injury in rat heart models exposed to different durations of ischemia with reperfusion. | 2004 | J. Nucl. Med. | pmid:15235074 |
| Ogi M et al. | [Comparison of intravenous ascorbic acid versus intravenous iron for functional iron deficiency in hemodialysis patients]. | 2004 | Nihon Jinzo Gakkai Shi | pmid:15645737 |
| Guz G et al. | Elevated cardiac troponin T in hemodialysis patients receiving more intravenous iron sucrose. | 2004 | Ren Fail | pmid:15600258 |
| Charytan C et al. | Safety of iron sucrose in hemodialysis patients intolerant to other parenteral iron products. | 2004 | Nephron Clin Pract | pmid:14988600 |
| Gupta KP and Singh J | Modulation of carcinogen metabolism and DNA interaction by calcium glucarate in mouse skin. | 2004 | Toxicol. Sci. | pmid:14976333 |
| Borawski J et al. | Endothelial injury markers with high-dose intravenous iron therapy in renal failure. | 2004 | Clin. Appl. Thromb. Hemost. | pmid:15497030 |